{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:51:01Z","timestamp":1782913861137,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Aging","award":["R01AG069976"],"award-info":[{"award-number":["R01AG069976"]}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["Grant 18232"],"award-info":[{"award-number":["Grant 18232"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01422-8","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:35:12Z","timestamp":1782912912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lewy pathology largely absent in prefrontal cortices of Parkinson\u2019s disease patients undergoing deep brain stimulation"],"prefix":"10.1038","volume":"12","author":[{"given":"Ariela S.","family":"Buxbaum Grice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Kopell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia F.","family":"Laborc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anina N.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Gonzalez Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Spadaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Ona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Crary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Charney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam D.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"1422_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson's disease. Nat. Rev. Dis. Prim. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1422_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature 610, 791\u2013795 (2022).","journal-title":"Nature"},{"key":"1422_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","volume":"8","author":"AW Willis","year":"2022","unstructured":"Willis, A. W. et al. Incidence of Parkinson's disease in North America. npj Parkinsons Dis. 8, 170 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"1422_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer, P. et al. Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson\u2019s disease. J. Neural Transm. 130, 627\u2013646 (2023).","journal-title":"J. Neural Transm."},{"key":"1422_CR5","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L- Stefanis","year":"2012","unstructured":"Stefanis, L. - Synuclein in Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med. 2, a009399 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1422_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., R\u00fcb, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"1422_CR7","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Shults","year":"2006","unstructured":"Shults, C. W. Lewy bodies. Proc. Natl. Acad. Sci. USA. 103, 1661\u20131668 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1422_CR8","doi-asserted-by":"crossref","unstructured":"Chu, Y., Hirst, W. D. & Kordower, J. H. Mixed pathology as a rule, not exception: Time to reconsider disease nosology. In Handbook of Clinical Neurology, vol. 192, 57\u201371 (Elsevier, 2023).","DOI":"10.1016\/B978-0-323-85538-9.00012-2"},{"key":"1422_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41582-018-0128-2","volume":"15","author":"AM Lozano","year":"2019","unstructured":"Lozano, A. M. et al. Deep brain stimulation: current challenges and future directions. Nat. Rev. Neurol. 15, 148\u2013160 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"1422_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1101\/sqb.2018.83.037440","volume":"83","author":"DJ Lee","year":"2018","unstructured":"Lee, D. J. & Lozano, A. M. Current status of deep brain stimulation for Alzheimer\u2019s disease: from chance observation to clinical trials. Cold Spring Harb. Symp. Quant. Biol. 83, 201\u2013205 (2018).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"1422_CR11","doi-asserted-by":"crossref","unstructured":"Hacker, M. L. et al. Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes. Neurology 95, e393\u2013e401 (2020).","DOI":"10.1212\/WNL.0000000000009946"},{"key":"1422_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1212\/CON.0000000000001152","volume":"28","author":"A Thaler","year":"2022","unstructured":"Thaler, A. & Alcalay, R. N. Diagnosis and medical management of Parkinson's disease. Continuum 28, 1281\u20131300 (2022).","journal-title":"Continuum"},{"key":"1422_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression, and mortality. Neurology 17, 427\u2013427 (1967).","journal-title":"Neurology"},{"key":"1422_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3171\/jns.1996.84.2.0203","volume":"84","author":"AL Benabid","year":"1996","unstructured":"Benabid, A. L. et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J. Neurosurg. 84, 203\u2013214 (1996).","journal-title":"J. Neurosurg."},{"key":"1422_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/00002512-200016040-00003","volume":"16","author":"J Marjama-Lyons","year":"2000","unstructured":"Marjama-Lyons, J. & Koller, W. Tremor-predominant Parkinson??s Disease: Approaches To Treatment. Drugs Aging 16, 273\u2013278 (2000).","journal-title":"Drugs Aging"},{"key":"1422_CR16","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","volume":"16","author":"N Tambasco","year":"2018","unstructured":"Tambasco, N., Romoli, M. & Calabresi, P. Levodopa in Parkinson\u2019s disease: current status and future developments. CN 16, 1239\u20131252 (2018).","journal-title":"CN"},{"key":"1422_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ana.23890","volume":"73","author":"R deSouza","year":"2013","unstructured":"deSouza, R., Moro, E., Lang, A. E. & Schapira, A. H. V. Timing of deep brain stimulation in Parkinson's disease: A need for reappraisal? Ann. Neurol. 73, 565\u2013575 (2013).","journal-title":"Ann. Neurol."},{"key":"1422_CR18","doi-asserted-by":"publisher","unstructured":"Liharska, L. E. et al. A study of gene expression in the living human brain. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-025-03163-1. (2025).","DOI":"10.1038\/s41380-025-03163-1"},{"key":"1422_CR19","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/mds.26435","volume":"30","author":"JG Hentz","year":"2015","unstructured":"Hentz, J. G. et al. Simplified conversion method for unified Parkinson\u2019s disease rating scale motor examinations. Mov. Disord. 30, 1967\u20131970 (2015).","journal-title":"Mov. Disord."},{"key":"1422_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamaneurol.2015.0606","volume":"72","author":"EJ Chung","year":"2015","unstructured":"Chung, E. J. et al. Clinical features of Alzheimer's disease with and without Lewy bodies. JAMA Neurol. 72, 789 (2015).","journal-title":"JAMA Neurol."},{"key":"1422_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado, H., Lin, W.-L., DeLucia, M. W. & Dickson, D. W. Alzheimer's disease with Amygdala Lewy bodies: a distinct form of \u03b1-Synucleinopathy. J. Neuropathol. Exp. Neurol. 65, 685\u2013697 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1422_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik, A., Stewart, T. & Zhang, J. Alpha-Synuclein as a biomarker for Parkinson\u2019s disease. Brain Pathol. 26, 410\u2013418 (2016).","journal-title":"Brain Pathol."},{"key":"1422_CR23","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology 65, 1863\u20131872 (2005).","journal-title":"Neurology"},{"key":"1422_CR24","doi-asserted-by":"crossref","unstructured":"Ho, D. E., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Soft. 42, 1\u201328 (2011).","DOI":"10.18637\/jss.v042.i08"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01422-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01422-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01422-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:35:21Z","timestamp":1782912921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01422-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01422-8","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Brian H. Kopell is a consultant for Medtronic, Abbott, and Turning Medical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}